Developing a new type of radiation detector for precise cancer treatment
Official title: Ultrafast FLASH radiation therapy dosimetry
Funded at University of Kansas Medical Center · NIH-10840959 · Data updated 2026-11-12
This study is working on a new type of radiation detector that can quickly and accurately measure radiation during FLASH therapy, a cutting-edge cancer treatment, to help make the therapy more effective for patients.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Medical Center NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project start | July 1, 2023 |
| Project end | June 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $172,098 |
| NIH project number | 5R21CA274193-02 |
| Project ID | NIH-10840959 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients undergoing radiation therapy for cancer who may benefit from enhanced treatment precision.
✕Less likely to help
Patients who are not receiving radiation therapy or those with conditions that do not require such treatment may not benefit from this research.
What this research studies
This research focuses on creating an innovative radiation detector that can measure radiation doses with exceptional speed and accuracy, specifically for FLASH radiation therapy, which is a promising cancer treatment. The project utilizes advanced low-gain-avalanche-detector technology combined with ultrafast electronics to achieve unprecedented temporal and spatial resolution in radiation measurement. By accurately capturing the details of radiation pulses, this technology aims to improve the effectiveness of radiation therapy for patients. The research is being conducted at the University of Kansas Medical Center and involves collaboration between engineers and biomedical researchers.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer radiation therapy for cancer patients, potentially improving treatment outcomes.
How similar studies have gone: Other research has shown promise in developing advanced radiation detection technologies, but this specific approach using LGAD technology is novel and has not been extensively tested in clinical settings.
Where this research is happening
-
University of Kansas Medical Center
Kansas City, United States Active
Researchers
- Principal investigator: Li, Harold Hui — University of Kansas Medical Center
- Study coordinator: Li, Harold Hui
Related research
Other NIH-funded projects on the same topics.
-
Protecting small blood vessels from radiation by boosting mitochondrial health
It aims to prevent radiation-related damage to tiny blood vessels and reduce later thinking and memory problems in people who get radiation therapy by protecting cell mitochondria.
-
Proton SBRT for refractory ventricular tachycardia with real-time 3D/4D imaging
A patient-facing study exploring a proton-based, noninvasive radiation therapy to treat stubborn VT using advanced 3D and 4D imaging to target the heart safely.
-
Embedding symptom support in radiation therapy for prostate cancer
A multi-site study tests whether delivering mindfulness-based symptom support right inside radiation therapy is feasible and acceptable for men with prostate cancer.
-
Targeting SREBP2 to boost radiation therapy in HPV-negative head and neck cancer
This grant aims to see if blocking SREBP2 can make radiation therapy work better for people with HPV-negative Head and Neck Squamous Cell Carcinoma.
-
Genetic and Immune Factors in Squaring the Room: Sacituzumab plus Radiation for Bladder Cancer
A study aims to understand why combining sacituzumab with radiation helps some bladder cancer patients more than others, with the goal of making bladder-sparing therapy more effective.
-
CivaDerm: a new four-day skin cancer radiation bandage
A new four‑day radiation bandage for non-melanoma skin cancer aims to treat facial and other areas without multiple clinic visits or big scars.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.